日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

一项针对晚期黑色素瘤、皮肤鳞状细胞癌、头颈部鳞状细胞癌或腺样囊性癌患者的瘤内注射CV8102的I期研究

Eigentler, Thomas; Thomas, Ioannis; Samoylenko, Igor; Erdmann, Michael; Heinzerling, Lucie; Ochsenreither, Sebastian; Krauss, Jürgen; Oberoi, Arjun; Robert, Caroline; Lebbe, Celeste; Martin-Liberal, Juan; Koch, Lukas; Richtig, Erika; Terheyden, Patrick; Weishaupt, Carsten; Mohr, Peter; Semiletova, Yulia; Perez, Casilda Llacer; Brossart, Peter; Bauernfeind, Franz Georg; Fluck, Michael; Poltoratskiy, Artem; Sekacheva, Marina; Soria, Ainara; Schmitt-Bormann, Beate; Gonzalez, Marina; Heß, Jana; Wengenmayer, Peter; Seibel, Tobias; Koch, Sven D; Quintini, Gianluca; Codó, Paula; Falk, Martin; Schönborn-Kellenberger, Oliver; Gnad-Vogt, Ulrike

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy

将PD-1抑制剂替换为BRAF+MEK抑制剂可提高接受第二疗程辅助黑色素瘤治疗患者的无复发生存期。

Schumann, Katharina; Klespe, Kai Christian; Mauch, Cornelia; Loquai, Carmen; Schultheis, Ulrike; Börger, Sevil; Thiem, Alexander; Emmert, Steffen; Hoellwerth, Magdalena; Kölblinger, Peter; Nguyen, Van Anh; Wanner, Marina; Richtig, Erika; Peitsch, Wiebke K; Harth, Wolfgang; Zenderowski, Veronika; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Johanna; Maul, Lara Valeska; Meiß, Frank; Rappersberger, Klemens; Persa, Oana Diana; Biedermann, Tilo; Posch, Christian

Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis

免疫检查点抑制剂诱导的黑色素瘤患者胰酶升高:发生率、管理和治疗——一项多中心分析

Brandlmaier, M; Hoellwerth, M; Silly, T; Hoeller, C; Koch, L; Richtig, E; Binder, K; Lange-Asschenfeldt, B; Barta, M; Schmid-Simbeck, M; Froehlich, F; Dummer, R; Muigg, L; Hitzl, W; Koelblinger, P

An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

一项开放标签、随机对照研究,比较美法仑/肝脏给药系统与最佳替代疗法治疗不可切除转移性葡萄膜黑色素瘤患者的疗效

Zager, Jonathan S; Orloff, Marlana; Ferrucci, Pier Francesco; Choi, Junsung; Eschelman, David J; Glazer, Evan S; Ejaz, Aslam; Howard, J Harrison; Richtig, Erika; Ochsenreither, Sebastian; Reddy, Sunil A; Lowe, Michael C; Beasley, Georgia M; Gesierich, Anja; Bender, Armin; Gschnell, Martin; Dummer, Reinhard; Rivoire, Michel; Arance, Ana; Fenwick, Stephen William; Sacco, Joseph J; Haferkamp, Sebastian; Weishaupt, Carsten; John, Johnny; Wheater, Matthew; Ottensmeier, Christian H

Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma

对不可切除的转移性葡萄膜黑色素瘤患者进行美法仑/肝脏递送系统3期FOCUS研究的亚组分析

Zager, Jonathan S; Orloff, Marlana; Ferrucci, Pier Francesco; Choi, Junsung; Eschelman, David J; Glazer, Evan S; Ejaz, Aslam; Richtig, Erika; Ochsenreither, Sebastian; Reddy, Sunil A; Lowe, Michael C; Beasley, Georgia M; Gesierich, Anja; Gschnell, Martin; Dummer, Reinhard; Arance, Ana; Fenwick, Stephen William; Sacco, Joseph J; John, Johnny; Wheater, Matthew; Ottensmeier, Christian H

High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial

高剂量糖皮质激素治疗与糖皮质激素替代治疗在免疫检查点抑制剂相关性垂体炎中的比较(CORTICI):一项开放标签、随机对照试验

Theiler-Schwetz, Verena; Trummer, Christian; Schmitt, Lisa; Terbuch, Angelika; Obermayer-Pietsch, Barbara; Richtig, Erika; Pilz, Stefan

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

转移性 BRAF V600 突变黑色素瘤的序贯免疫治疗和靶向治疗:II 期 SECOMBIT 试验的 4 年生存率和生物标志物评估

Paolo A Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fier

Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors

免疫检查点抑制剂治疗患者C反应蛋白早期变化与静脉血栓栓塞的关系

Moik, Florian; Riedl, Jakob M; Barth, Dominik; Berton, Franziska; Fink, Michael; Englisch, Cornelia; Hoeller, Christoph; Fuereder, Thorsten; Ay, Leyla; Pabinger, Ingrid; Richtig, Erika; John, Nikolaus; Kostmann, Sarah M; Jost, Philipp J; Gerger, Armin; Terbuch, Angelika; Preusser, Matthias; Ay, Cihan

Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation

晚期黑色素瘤的特点是 NLGN4X 表达低,导致 HIF1A 积累

David Schörghofer #, Laurenz Vock #, Madalina A Mirea, Oliver Eckel, Anna Gschwendtner, Jürgen Neesen, Erika Richtig, Markus Hengstschläger, Mario Mikula

Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study

美法仑/肝脏递送系统治疗不可切除转移性葡萄膜黑色素瘤患者的疗效和安全性:一项开放标签、单臂、多中心3期研究的结果

Zager, Jonathan S; Orloff, Marlana; Ferrucci, Pier Francesco; Choi, Junsung; Eschelman, David J; Glazer, Evan S; Ejaz, Aslam; Howard, J Harrison; Richtig, Erika; Ochsenreither, Sebastian; Reddy, Sunil A; Lowe, Michael C; Beasley, Georgia M; Gesierich, Anja; Bender, Armin; Gschnell, Martin; Dummer, Reinhard; Rivoire, Michel; Arance, Ana; Fenwick, Stephen William; Sacco, Joseph J; Haferkamp, Sebastian; Weishaupt, Carsten; John, Johnny; Wheater, Matthew; Ottensmeier, Christian H